BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22297630)

  • 1. Systemic antifungal therapy in critically ill patients without invasive fungal infection*.
    Azoulay E; Dupont H; Tabah A; Lortholary O; Stahl JP; Francais A; Martin C; Guidet B; Timsit JF
    Crit Care Med; 2012 Mar; 40(3):813-22. PubMed ID: 22297630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
    Cohen Y; Karoubi P; Adrie C; Gauzit R; Marsepoil T; Zarka D; Clec'h C
    Crit Care Med; 2010 Mar; 38(3):826-30. PubMed ID: 20042858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
    Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
    Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients.
    Bailly S; Bouadma L; Azoulay E; Orgeas MG; Adrie C; Souweine B; Schwebel C; Maubon D; Hamidfar-Roy R; Darmon M; Wolff M; Cornet M; Timsit JF
    Am J Respir Crit Care Med; 2015 May; 191(10):1139-46. PubMed ID: 25780856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida prophylaxis and therapy in the ICU.
    Echeverria PM; Kett DH; Azoulay E
    Semin Respir Crit Care Med; 2011 Apr; 32(2):159-73. PubMed ID: 21506052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
    Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
    Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.
    Garey KW; Neuhauser MM; Bearden DT; Cannon JP; Lewis RE; Gentry LO; Kontoyiannis DP
    Mycoses; 2006 May; 49(3):226-31. PubMed ID: 16681815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
    Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
    Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society.
    Yamamura DL; Rotstein C; Nicolle LE; Ioannou S
    CMAJ; 1999 Feb; 160(4):493-9. PubMed ID: 10081465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient.
    Garnacho-Montero J; Olaechea P; Alvarez-Lerma F; Alvarez-Rocha L; Blanquer J; Galván B; Rodriguez A; Zaragoza R; Aguado JM; Mensa J; Solé A; Barberán J
    Rev Esp Quimioter; 2013 Jun; 26(2):173-88. PubMed ID: 23817660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiology of candidemia: a one-year prospective observational study in the west of France].
    Talarmin JP; Boutoille D; Tattevin P; Dargère S; Weinbreck P; Ansart S; Chennebault JM; Hutin P; Léautez-Nainville S; Gay-Andrieu F; Raffi F;
    Med Mal Infect; 2009 Dec; 39(12):877-85. PubMed ID: 19346088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antifungal treatment for suspected or proved candidiasis in the critically ill].
    Massanet P; Jung B; Molinari N; Villiet M; Moulaire V; Roch-Torreilles I; Jaber S; Reynes J; Corne P
    Ann Fr Anesth Reanim; 2014 Apr; 33(4):232-9. PubMed ID: 24684836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of fluconazole administration on outcomes in critically ill patients.
    Garrelts JC; Schroeder TR; Harrison PB
    Ann Pharmacother; 2004 Oct; 38(10):1588-92. PubMed ID: 15340132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Number of sites of perinatal Candida colonization and neutropenia are associated with nosocomial candidemia in the neonatal intensive care unit patient.
    Mahieu LM; Van Gasse N; Wildemeersch D; Jansens H; Ieven M
    Pediatr Crit Care Med; 2010 Mar; 11(2):240-5. PubMed ID: 19794324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiological study of invasive nosocomial candidiasis in 2 teaching hospitals in Beijing].
    Cao B; Wang H; Wu L; Sun WJ; Li F; Liu YM
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1970-3. PubMed ID: 19062737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preemptive therapy in nonneutropenic patients with Candida infection using the Japanese guidelines.
    Tsuruta R; Mizuno H; Kaneko T; Oda Y; Kaneda K; Fujita M; Inoue T; Kasaoka S; Maekawa T
    Ann Pharmacother; 2007 Jul; 41(7):1137-43. PubMed ID: 17535843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study.
    Manzoni P; Arisio R; Mostert M; Leonessa M; Farina D; Latino MA; Gomirato G
    Pediatrics; 2006 Jan; 117(1):e22-32. PubMed ID: 16326690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.